Unapproved drugs in the united states and the food and drug administration

Advances in Therapy

Volumn 28, Issue 10, 2011, Pages 842-856

  Nasr, Alexander ^a   Lauterio, Thomas J ^a   Davis, Matthew W ^a  

^a Mutual Pharmaceutical Company Inc   (United States)

Author keywords

drug approval; FDA; unapproved drugs

Indexed keywords

ALPHA TOCOPHEROL; ALPHAPRODINE; AMITRIPTYLINE; BUPHENINE; CARBINOXAMINE; CHLORDIAZEPOXIDE; CHLOROTHIAZIDE; CHLORPROMAZINE; COLCHICINE; CYTOCHROME P450 3A4; DARBAZINE; DEXTROPROPOXYPHENE; EQUAGESIC; GENERIC DRUG; GLYCERYL TRINITRATE; GUAIFENESIN; HEPARIN; HYDROCORTISONE ACETATE; ILLICIT DRUG; ISONIAZID; ISOPROPAMIDE IODIDE PLUS PROCHLORPERAZINE MALEATE; ISOSORBIDE DINITRATE; LEVOTHYROXINE; MARAX; METHOTREXATE; METHYLPREDNISOLONE ACETATE PLUS NEOMYCIN; NEO MEDROL; PLACEBO; RAUTRAX; THALIDOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN;

ACUTE KIDNEY FAILURE; BONE MARROW SUPPRESSION; CONGESTIVE HEART FAILURE; CONSUMER; DIARRHEA; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG MEGADOSE; DRUG RESEARCH; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; GOUT; HUMAN; LAW ENFORCEMENT; LEGAL ASPECT; LOW DRUG DOSE; MUSCLE DISEASE; NEUROLOGIC DISEASE; NEUTROPENIA; PANCYTOPENIA; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TERATOGENICITY; THROMBOCYTOPENIA; UNITED STATES;

CONSUMER PRODUCT SAFETY; DECISION TREES; DRUG APPROVAL; DRUG INDUSTRY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LAW ENFORCEMENT; SAFETY-BASED DRUG WITHDRAWALS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 82355185799     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-011-0059-4     Document Type: Review

References (32)

1. US Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Marketed Unapproved Drugs - Compliance Policy Guide. June 2006. Available at: http://www.fda.gov/ICECI/ ComplianceManuals/CompliancePolicyGuidanceManual/UCM074382. Accessed March 26, 2011.
2. C.D. Fisher 1909 Wiley and the Pure Food Laws Progress 8 91 94
3. I.D. Barkan 1985 Industry invites regulation: the passage of the Pure Food and Drug Act of 1906 Am J Public Health 75 18 26 3881052 10.2105/AJPH.75.1.18 1:STN:280:DyaL2M%2FpsVKqsA%3D%3D (Pubitemid 15194819)
4. Upton Sinclair. Encyclopedia Britannica. Encyclopedia Britannica Online. Encyclopedia Britannica, 2011. Available at: http://www.britannica.com/ EBchecked/topic/545642/Upton-Sinclair. Accessed March 26, 2011.
5. R. Chhabrar M.E. Kremzner B.J. Kiliany 2005 FDA policy on unapproved drug products: past, present, and future Ann Pharmacother 39 1260 1264 10.1345/aph.1E569 (Pubitemid 40943179)
6. Ballentine C. Taste of raspberries, taste of death: the 1937 Elixir Sulfanilamide Incident. FDA Consumer Magazine, June 1981. Available at: http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/ SulfanilamideDisaster/default.htm. Accessed March 26, 2011.
7. V.V. Moghe U. Kulkarni U.I. Parmar 2008 Thalidomide Bombay Hosp J 50 472 476
8. R. von Moos R. Stolz T. Cherny K. Gillessen 2003 Thalidomide: from tragedy to promise Swiss Med Wkly 133 77 87 (Pubitemid 36329147)
9. Bren L. Frances Oldham Kelsey: FDA Medical Reviewer leaves her mark on history. FDA Consumer Magazine, Mar-Apr 2001. Available at: http://permanent. access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/201-kelsey.html. Accessed March 26, 2011.
10. J. Botting 2002 The history of thalidomide Drug News Perspect 15 604 611 12677202 10.1358/dnp.2002.15.9.840066 1:CAS:528:DC%2BD3sXlt1aktg%3D%3D (Pubitemid 36025547)
11. W.A. Silverman 2002 The schizophrenic career of a "monster drug" Pediatrics 110 404 406 12165600 10.1542/peds.110.2.404 (Pubitemid 34833032)
12. Autor DM. The Unapproved Universe. January 9, 2007. Available at: http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ucm118338.pdf. Accessed March 26, 2011.
13. Karst KR. Marketed unapproved drugs: overview and FDA enforcement policies. August 10, 2006. Available at: http://www.hpm.com/pdf/ MARKETED%20UNAPROVED%20DRUGS-%20OVERVIEW.pdf. Accessed March 27, 2011.
14. Approved Drug Decision Tree. Available at: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ SelectedEnforcementActionsonUnapprovedDrugs/ucm119916.pdf. Accessed March 27, 2011.
15. US Department of HealthHuman Services. 2007 Food and Drug Administration. Timed-release drug products containing guaifenesin; enforcement action Federal Register 72 29517 29519
16. US Department of HealthHuman Services. 2006 Food and Drug Administration. Carbinoxamine products; enforcement action dates Federal Register 71 33462 33462
17. US Department of Health and Human Services Food and Drug Administration. Press release: FDA orders 2 companies to stop marketing unapproved nitroglycerin tablets. March 16, 2010. Available at: http://www.fda.gov/newsevents/newsroom/ pressannouncements/ucm204744.htm. Accessed March 27, 2011.
18. US Department of Health and Human Services. Food and Drug Administration. Questions and answers for consumers about FDA's action involving unapproved nitroglycerin sublingual tablets. March 16, 2010. Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/ ucm204351.htm. Accessed March 27, 2011.
19. US Department of HealthHuman Services. 2008 Food and Drug Administration. Drug products containing colchicine for injection; enforcement action Federal Register 75 7565 7567
20. P.A. Simkin G.C. Gardner 2000 Colchicine use in cyclosporine treated transplant recipients: how little is too much? J Rheumatol 27 1334 1337 10852250 1:STN:280:DC%2BD3cvotlCqsQ%3D%3D (Pubitemid 30354024)
21. K.V. Speeg A.L. Maldonado J. Liaci D. Muirhead 1992 Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo Hepatology 15 899 903 1568732 10.1002/hep.1840150524 1:CAS:528:DyaK38XisVOrtbk%3D
22. K.V. Speeg A.L. Maldonado J. Liaci D. Muirhead 1992 Effect of cyclosporine on colchicine secretion by a kidney multidrug transporter studied in vivo J Pharmacol Exp Ther 261 50 55 1348538 1:CAS:528:DyaK38Xit1Orur4%3D
23. G. Cocco D.C.C. Chu S. Pandolfi 2010 Colchicine in clinical medicine. A guide for internists Eur J Intern Med 21 502 508 10.1016/j.ejim.2010.09.010
24. L.P.H. Yang 2010 Oral colchicine (Colcrys) in the treatment and prophylaxis of gout Drugs 70 1603 1613 20687623 10.2165/11205470-000000000-00000 1:CAS:528:DC%2BC3cXhtF2ks7jM
25. E. Niel J.M. Scherrmann 2006 Colchicine today Joint Bone Spine 73 672 678 17067838 10.1016/j.jbspin.2006.03.006 1:CAS:528:DC%2BD2sXhsFahu70%3D (Pubitemid 44932240)
26. Y. Finkelstein S.E. Aks J.R. Hutson, et al. 2010 Colchicine poisoning: the dark side of an ancient drug Clin Toxicol (Phila) 48 1422 1431 10.3109/15563650.2010.495348
27. Food and Drug Administration Information for Healthcare Professionals: New Safety Information for Colchicine. 2009. Available at: http://www.fda.gov/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm174315.htm. Accessed July 5, 2011.
28. US Department of HealthHuman Services. 2010 Food and Drug Administration. Single-ingredient oral colchicine products; enforcement action dates Federal Register 73 60768 60771
29. Colcrys® Full Prescribing Information. September 6, 2010. Available at: http://www.colcrys.com/assets/pdf/COLCRYS-Full-Prescribing-Information.pdf. Accessed March 28, 2011.
30. A.D. Kesselheim D.H. Solomon 2010 Incentives for drug development. The curious case of colchicine N Engl J Med 362 2045 2047 20393164 10.1056/NEJMp1003126 1:CAS:528:DC%2BC3cXntVajt7Y%3D
31. R.A. Terkeltaub D.E. Furst K. Bennett K.A. Kook R.S. Crockett M.W. Davis 2010 High versus low dosing of oral colchicine for early acute gout flare: twenty-fourhour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study Arthritis Rheum 62 1060 1068 20131255 10.1002/art.27327 1:CAS:528:DC%2BC3cXhtFGnu7rE
32. V. Jayaprakash G. Ansell D. Galler 2007 Colchicine overdose: the devil in the detail NZ Med J 120 U2402